Cancer Institute A national cancer institute
designated cancer center

John Ioannidis

Publication Details

  • Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

    Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, Gluud LL, Als-Nielsen B, Gluud C. Int J Epidemiol. 2009; 38 (1): 276-86

    Results from apparently conclusive meta-analyses may be false. A limited number of events from a few small trials and the associated random error may be under-recognized sources of spurious findings. The information size (IS, i.e. number of participants) required for a reliable and conclusive meta-analysis should be no less rigorous than the sample size of a single, optimally powered randomized clinical trial. If a meta-analysis is conducted before a sufficient IS is reached, it should be evaluated in a manner that accounts for the increased risk that the result might represent a chance finding (i.e. applying trial sequential monitoring boundaries).

    PubMedID: 18824467

Stanford Medicine Resources:

Footer Links: